Founder of Paindrainer AB 2018

Professor Carl Borrebaeck,is a company builder who previously founded the Nasdaq listed companiesImmunovia AB, Senzagen AB, BioInvent Int. AB, and Alligator BioScience AB.

Carl Borrebaeck has several awards, such as Akzo Nobel’s Science Prize (2009); Royal Engineering AcademyGold Medal (2012), and he was appointed the Biotech Builder of the year 2017for his entrepreneurship. He is the Director of CREATE Health Strategic Centerfor Translational Cancer Research, a permanent member of the Royal Academy ofEngineering Sciences, and former vice president of Lund University. CarlBorrebaeck is also the Founding Mentor for Nordic Mentor Network forEntrepreneurship (NOME).

Current appointments: Chairman of SenzaGen AB and CB Ocean CapitalAB. 

Elected 2021

Peter Benson led the formation of Sunstone Life Science Ventures and served as its Managing Partner from 2007-2019. In addition, Peter Benson has extensive experience from the Global Life Science industry as an investor, founder, board member and senior executive, including 10 listed companies. Previous positions include Head of Life Science Ventures at Vækstfonden (the Danish Growth Fund), President of the Hospital Care Division and Senior Vice President at Pharmacia AB as well as Executive Vice President Marketing & Sales at Kabi Pharmacia Parenterals.

Current appointments: Chairman of Ascelia AB (pub.), Ascelia Incentive AB and Sunstone Life Science Ventures ApS.

Elected 2022

Mattias Ohlsson is a professor at the department of Astronomy and Theoretical Physics, Lund University. He is also a professor of Information Technology at Halmstad University. His research interests focus on AI and machine learning and its applications within the healthcare sector. Mattias has previous experience in developing AI based medical devices such as some of the products manufactured by Exini Diagnostics AB.

Elected 2023

Philip Siberg is a serial entrepreneur in the Life Science industry, M&A advisor, and has a background in venture capital industry. He has a MSc. in Engineering and Industrial Economics from the Royal Institute ofEngineering (KTH) in Stockholm. Philip Siberg has extensive international experience previously residing and working several times in the US and in the UK. He has led two companies to Nasdaq, served as CEO and Chairman of public life science companies, secured four FDA 510(k) clearances, and raised over USD 100 million for various ventures.

Current appointments: Partner of Southbloom Corporate Finance, Chairman of Senzime AB and Acarix AB, both Nasdaq-listed medical device companies, Chairman and co-founder or EEP Capital, a California-based Venture Capital firm investing into US-based Padel projects.

Elected 2023

Linda Nyberg has a solid background in media and has worked in corporate communications, public affairs, crisis communication including marketing for multinational stock-listed companies. Linda Nyberg has held several seniorkey roles in primarily the health sector. Linda Nyberg was previously the Group Corporate Affairs and Brand Director at AniCura, Vice President Media Communications at Essity, listed on Nasdaq, Chief Marketing Officer at Apoteket AB, and VP International Affairs and Communications in the Swedish med-tech company Bactiguard.

Current appointments: Chief Communications Officer at Novatron Fusion Group AB, board member C Green Technology and Flarie AB and part of the Advisory Board of The Techarena, UNHCR for Sweden and the Swedish Teacher’s Award, Lärargalan. 

Joined Paindrainer AB 2022

Erik Frick is a successful business leader and has extensive experience working with digital products and commercial activities.

Prior to Paindrainer, Erik worked as COO and Vice President at Resurs Bank, where he took lead in corporate strategies, business development, and was responsible for the development and commercialization of their fintech app, which had around a quarter million users. He also has experience as a board member at Kivra OY during their launch phase in the Finnish market.

Erik holds an MSC in Entrepreneurship and Business Design from Chalmers University of Technology.

Joined Paindrainer AB 2022

Jakob Berglund is a passionate full-stack developer with a focus on modern applications.

Prior to Paindrainer, Jakob worked as Customer Success and Business Development Manager at Flatfrog where he was responsible being the customer voice in the management- and development team. He also has co-founded and developed Unified Remote which is one of the most downloaded Swedish Android and IOS apps with over 10 million installs.

Jakob holds a MSC in Computer Science from Lund Institute of Technology.

Founder of Paindrainer AB 2018

Maria Rosén Klement is a dedicated founder and inventor of Paindrainer.

Maria has research experience in immunology, lipid biochemistry, and protein fold prediction from Stockholm University and Karolinska Institutet. Maria lives with chronic pain and got the idea for Paindrainer after struggling to adapt to life changes following an injury and meeting others who face similar challenges living with persistent pain.

Maria holds a BSc in Biochemistry, an MSc in Molecular Biology from Umeå University, and a PhD in Biochemistry from Stockholm University.

Joined Paindrainer AB 2023

Elin Algotsson is a highly experienced professional within Regulatory Affairs and Quality Assurance for medical devices.

Prior to Paindrainer, Elin worked as Regulatory Affairs Manager at Atos Medical AB, the global leader in laryngectomy care as well as a leading developer and manufacturer of tracheostomy products with distribution to over 90 countries. Her responsibilities included implementation of standard operating procedures for global compliance, regulatory intelligence, CAPA and audit management, worldwide product registrations and final review of promotional materials.

Elin holds a MSC in Engineering from the Royal Institute of Technology in Stockholm.

Antje M.Barreveld, M.D. is Medical Director of Pain Management Services and co-Founder and Director of Education and Outreach for Substance Use Services (SUS) at Newton-Wellesley Hospital. Dr. Barreveld is Associate Professor of Anesthesiology at Tufts University School of Medicine, and an Anesthesiologist at Newton-Wellesley Hospital. Dr. Barreveld is also Clinical Researcher at Harvard Medical School in the Department of Anesthesiology, Perioperative and Pain Medicine at Brigham and Women's Hospital in Boston.

Nationally, Dr. Barreveld serves in numerous leadership and pain advocacy roles. She is co-Editor for the Education Section of Pain Medicine, the official journal of the American Academy of Pain Medicine, for whom she also serves as an elected Board member. She has authored numerous peer-reviewed publications in high-ranking scientific journals including the New England Journal of Medicine, Pain Medicine, Anesthesiology, Regional Anesthesia and Pain Medicine, and Anesthesia & Analgesia. Dr. Barreveld is a 2020 Mayday Pain & Society Fellow, selected as one of 12 national Fellows to build the next generation of pain experts to provide evidence-based and solutions-focused information about pain care and treatment as well as promising research emerging in the field.

Hans Lindroth has extensive experience in venture investing and has beeninvolved in 60+ companies within IT, biotech, hospitality, and real estatedevelopment on four continents. Lindroth is co-founder of several companies andis heavily engaged in charitable activities in education, culture and social work:with a special mission on supporting deprived children. Hans Lindroth is speakeron new technology and new media. Former hockey player.

‍

With a portfolio of expertise and notable achievements, Dr. Grelz stands as a prominent figure in the realms of Pain Medicine and General Practice.

His dedication to advancing his field is exemplified through his active engagement in pain education at Lund University's medical school. This involvement underscores his role in shaping the next generation of medical professionals, fostering a legacy of expertise and compassion.

As a PhD student at Lund University's Faculty of Clinical Sciences in Malmö. His specialized focus on chronic non-cancer pain and long-term opioid use positions him to address critical challenges in contemporary pain management. By enhancing our understanding of pain and its treatments, Dr. Grelz is committed to improving patient well-being.

Beyond academia, Dr. Grelz's impact resonates through pioneering research endeavors. He currently contributes to a nationwide project in Sweden, exploring biomarkers in chronic pain patients. This groundbreaking work carries the potential to redefine pain diagnosis and treatment, ushering in personalized and effective approaches.

His influence extends to policy and advocacy, evidenced by his role as a boardmember in the regional committee for pain care in southern Sweden. By actively shaping policies he is improving patient outcomes and quality of life, particularly for individuals living with chronic pain.

‍